Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
10.04
-0.19 (-1.86%)
At close: Aug 21, 2026, 4:00 PM EDT
10.20
+0.16 (1.59%)
After-hours: Aug 21, 2026, 7:37 PM EDT
Cartesian Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 147.61 | 125.14 | 212.61 | 76.91 | 106.44 | 4.74 |
Short-Term Investments | - | - | - | - | 28.16 | - |
Cash & Short-Term Investments | 147.61 | 125.14 | 212.61 | 76.91 | 134.6 | 4.74 |
Cash Growth | -7.93% | -41.14% | 176.44% | -42.86% | 2742.70% | - |
Accounts Receivable | 0.2 | 1.12 | 0.87 | 8.85 | 9.76 | 3.13 |
Other Receivables | - | - | - | - | - | 0.23 |
Receivables | 0.2 | 1.12 | 0.87 | 8.85 | 9.76 | 3.35 |
Prepaid Expenses | 5.81 | 3.02 | 3.14 | 4.97 | 3.49 | 0.05 |
Restricted Cash | - | - | - | - | 0.29 | - |
Total Current Assets | 153.62 | 129.28 | 216.63 | 90.73 | 148.14 | 8.14 |
Property, Plant & Equipment | 16.44 | 17.79 | 15.45 | 12.18 | 14.41 | 1.5 |
Long-Term Investments | - | - | 2 | 2 | 2 | - |
Goodwill | 48.16 | 48.16 | 48.16 | 48.16 | - | - |
Other Intangible Assets | 93.9 | 93.9 | 150.6 | 150.6 | - | - |
Other Long-Term Assets | 6.52 | 7.29 | 2.19 | 1.38 | 1.34 | 0.03 |
Total Assets | 318.63 | 296.41 | 435.02 | 305.05 | 165.89 | 9.67 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.05 | 1.29 | 0.29 | 3.15 | 0.32 | - |
Accrued Expenses | 14.07 | 9.16 | 11.24 | 14.61 | 14.08 | 0.79 |
Current Portion of Long-Term Debt | - | - | - | - | 8.48 | - |
Current Portion of Leases | 4.2 | 4.15 | 2.85 | 2.17 | 1.61 | 0.17 |
Current Unearned Revenue | - | - | - | 2.31 | 0.59 | 0.12 |
Other Current Liabilities | 1.24 | 0.34 | 8.6 | 45.98 | - | 0.19 |
Total Current Liabilities | 20.55 | 14.94 | 22.98 | 68.21 | 25.08 | 1.27 |
Long-Term Debt | 52.85 | - | - | - | 17.79 | - |
Long-Term Leases | 6.81 | 8.53 | 11.13 | 8.79 | 10.06 | 1.11 |
Long-Term Unearned Revenue | - | - | - | 3.54 | - | - |
Long-Term Deferred Tax Liabilities | 6.95 | 6.95 | 16.14 | 15.85 | - | - |
Other Long-Term Liabilities | 356.7 | 392.24 | 391.58 | 348.29 | 19.14 | 0.35 |
Total Liabilities | 443.85 | 422.65 | 441.83 | 444.68 | 72.06 | 2.72 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0.02 | - |
Additional Paid-In Capital | 725.17 | 700.71 | 689.89 | 179.06 | 493.31 | 6.64 |
Retained Earnings | -845.79 | -822.37 | -692.07 | -614.65 | -394.94 | -19.61 |
Comprehensive Income & Other | -4.61 | -4.58 | -4.62 | -4.6 | -4.56 | - |
Total Common Equity | -125.23 | -126.24 | -6.8 | -440.18 | 93.83 | -12.97 |
Shareholders' Equity | -125.23 | -126.24 | -6.8 | -139.63 | 93.83 | 6.95 |
Total Liabilities & Equity | 318.63 | 296.41 | 435.02 | 305.05 | 165.89 | 9.67 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 63.85 | 12.68 | 13.98 | 10.96 | 37.93 | 1.28 |
Net Cash (Debt) | 83.75 | 112.46 | 198.63 | 65.96 | 96.68 | 3.46 |
Net Cash Growth | -43.02% | -43.38% | 201.15% | -31.78% | 2698.18% | - |
Net Cash Per Share | 3.09 | 4.33 | 11.44 | 12.76 | 19.88 | 0.91 |
Filing Date Shares Outstanding | 30.26 | 26.51 | 25.91 | 5.4 | - | 3.81 |
Total Common Shares Outstanding | 30.04 | 26.01 | 25.77 | 5.4 | - | 3.81 |
Working Capital | 133.07 | 114.34 | 193.65 | 22.52 | 123.06 | 6.87 |
Book Value Per Share | -4.17 | -4.85 | -0.26 | -81.55 | - | - |
Tangible Book Value | -267.29 | -268.3 | -205.57 | -638.95 | 93.83 | -12.97 |
Tangible Book Value Per Share | -8.90 | -10.31 | -7.98 | -118.38 | - | - |
Machinery | 10.31 | 9.28 | 8.15 | 7.63 | 7.34 | 0.78 |
Construction In Progress | 0.3 | 3.47 | 0.7 | 0.15 | 0.6 | - |
Leasehold Improvements | 6.83 | 4.18 | 3.43 | 0.06 | 0.06 | - |